My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 92

    1.

    Relationship of family history of type 2 diabetes, hypoglycemia, and autoantibodies to weight gain and lipids with intensive and conventional therapy in the Diabetes Control and Complications Trial.

    Purnell JQ, Dev RK, Steffes MW, Cleary PA, Palmer JP, Hirsch IB, Hokanson JE, Brunzell JD.

    Diabetes. 2003 Oct;52(10):2623-9.PMID: 14514648 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: results from the DCCT. Diabetes Control and Complications Trial.

    Purnell JQ, Hokanson JE, Marcovina SM, Steffes MW, Cleary PA, Brunzell JD.

    JAMA. 1998 Jul 8;280(2):140-6. Erratum in: JAMA 1998 Nov 4;280(17):1484. PMID: 9669786 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the diabetes control and complications trial.

    Schaumberg DA, Glynn RJ, Jenkins AJ, Lyons TJ, Rifai N, Manson JE, Ridker PM, Nathan DM.

    Circulation. 2005 May 17;111(19):2446-53. Epub 2005 May 2.PMID: 15867184 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Weight gain associated with intensive therapy in the diabetes control and complications trial. The DCCT Research Group.

    [No authors listed]

    Diabetes Care. 1988 Jul-Aug;11(7):567-73.PMID: 2904881 [PubMed - indexed for MEDLINE]Related articles

    5.

    Deleterious effects of increased body weight associated with intensive insulin therapy for type 1 diabetes: increased blood pressure and worsened lipid profile partially negate improvements in life expectancy.

    Palmer AJ, Roze S, Valentine WJ, Minshall ME, Lammert M, Nicklasson L, Spinas GA.

    Curr Med Res Opin. 2004 Aug;20 Suppl 1:S67-73.PMID: 15324518 [PubMed - indexed for MEDLINE]Related articles

    6.

    Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes.

    Abraira C, Colwell JA, Nuttall FQ, Sawin CT, Nagel NJ, Comstock JP, Emanuele NV, Levin SR, Henderson W, Lee HS.

    Diabetes Care. 1995 Aug;18(8):1113-23.PMID: 7587846 [PubMed - indexed for MEDLINE]Related articles

    7.

    U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group.

    [No authors listed]

    Diabetes. 1995 Nov;44(11):1249-58. Erratum in: Diabetes 1996 Nov;45(11):1655. PMID: 7589820 [PubMed - indexed for MEDLINE]Related articles

    8.

    Hypoglycemia in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group.

    [No authors listed]

    Diabetes. 1997 Feb;46(2):271-86.PMID: 9000705 [PubMed - indexed for MEDLINE]Related articles

    9.

    Implementation of treatment protocols in the Diabetes Control and Complications Trial.

    [No authors listed]

    Diabetes Care. 1995 Mar;18(3):361-76.PMID: 7555480 [PubMed - indexed for MEDLINE]Related articles

    10.

    Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group.

    [No authors listed]

    Ann Intern Med. 1998 Apr 1;128(7):517-23.PMID: 9518395 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Improved glycemic control reduces the impact of weight gain on cardiovascular risk factors in type 1 diabetes. The Epidemiology of Diabetes Complications Study.

    Williams KV, Erbey JR, Becker D, Orchard TJ.

    Diabetes Care. 1999 Jul;22(7):1084-91.PMID: 10388972 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Relationship between ethnicity and glycemic control, lipid profiles, and blood pressure during the first 9 years of type 2 diabetes: U.K. Prospective Diabetes Study (UKPDS 55).

    Davis TM, Cull CA, Holman RR; U.K. Prospective Diabetes Study (UKPDS) Group.

    Diabetes Care. 2001 Jul;24(7):1167-74.PMID: 11423497 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Epidemiology of severe hypoglycemia in the diabetes control and complications trial. The DCCT Research Group.

    [No authors listed]

    Am J Med. 1991 Apr;90(4):450-9.PMID: 2012085 [PubMed - indexed for MEDLINE]Related articles

    14.

    Weight gain is associated with improved glycaemic control but with adverse changes in plasma lipids and blood pressure isn Type 1 diabetes.

    Ferriss JB, Webb D, Chaturvedi N, Fuller JH, Idzior-Walus B; EURODIAB Prospective Complications Group.

    Diabet Med. 2006 May;23(5):557-64.PMID: 16681565 [PubMed - indexed for MEDLINE]Related articles

    15.

    Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group.

    [No authors listed]

    Diabetes. 1997 Nov;46(11):1829-39.PMID: 9356033 [PubMed - indexed for MEDLINE]Related articles

    16.

    The impact of outpatient diabetes management on serum lipids in urban African-Americans with type 2 diabetes.

    Erdman DM, Cook CB, Greenlund KJ, Giles WH, El-Kebbi I, Ryan GJ, Gallina DL, Ziemer DC, Dunbar VG, Phillips LS.

    Diabetes Care. 2002 Jan;25(1):9-15.PMID: 11772894 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Inhaled insulin improves glycemic control when substituted for or added to oral combination therapy in type 2 diabetes: a randomized, controlled trial.

    Rosenstock J, Zinman B, Murphy LJ, Clement SC, Moore P, Bowering CK, Hendler R, Lan SP, Cefalu WT.

    Ann Intern Med. 2005 Oct 18;143(8):549-58.PMID: 16230721 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Effect of intensive glycemic control on fibrinogen, lipids, and lipoproteins: Veterans Affairs Cooperative Study in Type II Diabetes Mellitus.

    Emanuele N, Azad N, Abraira C, Henderson W, Colwell J, Levin S, Nuttall F, Comstock J, Sawin C, Silbert C, Marcovina S, Lee HS.

    Arch Intern Med. 1998 Dec 7-21;158(22):2485-90.PMID: 9855387 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Effect of obesity on the response to insulin therapy in noninsulin-dependent diabetes mellitus.

    Yki-Järvinen H, Ryysy L, Kauppila M, Kujansuu E, Lahti J, Marjanen T, Niskanen L, Rajala S, Salo S, Seppälä P, Tulokas T, Viikari J, Taskinen MR.

    J Clin Endocrinol Metab. 1997 Dec;82(12):4037-43.PMID: 9398709 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Triple therapy with glimepiride in patients with type 2 diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group study.

    Roberts VL, Stewart J, Issa M, Lake B, Melis R.

    Clin Ther. 2005 Oct;27(10):1535-47.PMID: 16330290 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity